These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32473213)

  • 1. Quantitative Evaluation of the Crystallinity of Indomethacin Using
    Okada K; Hayashi Y; Kumada S; Onuki Y
    J Pharm Sci; 2020 Aug; 109(8):2577-2584. PubMed ID: 32473213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the Solid Content of Active Pharmaceutical Ingredient Powders in Suspension-Type Pharmaceutical Oral Jelly Using Time-Domain NMR.
    Kobayashi R; Ono T; Kumada S; Okada K; Onuki Y
    Chem Pharm Bull (Tokyo); 2023; 71(11):838-842. PubMed ID: 37914260
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Okada K; Hirai D; Kumada S; Kosugi A; Hayashi Y; Onuki Y
    J Pharm Sci; 2019 Jan; 108(1):451-456. PubMed ID: 30267784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T
    Okada K; Hirai D; Hayashi Y; Kumada S; Kosugi A; Onuki Y
    Chem Pharm Bull (Tokyo); 2019; 67(6):580-586. PubMed ID: 31155564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Salt and Free Base of Active Pharmaceutical Ingredients Based on NMR Relaxometry Measured by Time Domain NMR.
    Chiba Y; Okada K; Hayashi Y; Leong KH; Kumada S; Onuki Y
    Chem Pharm Bull (Tokyo); 2022; 70(2):162-168. PubMed ID: 35110437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Approach to Evaluate Amorphous-to-Crystalline Transformation of Active Pharmaceutical Ingredients in Solid Dispersion Using Time-Domain NMR.
    Okada K; Hirai D; Hayashi Y; Kumada S; Kosugi A; Onuki Y
    Chem Pharm Bull (Tokyo); 2019; 67(3):265-270. PubMed ID: 30828003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Time-Domain NMR for
    Okada K; Ono T; Hayashi Y; Kumada S; Onuki Y
    J Pharm Sci; 2024 Mar; 113(3):680-687. PubMed ID: 37659719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Time-Domain NMR Study to Evaluate Physical Properties of Pharmaceutical Dosage Forms for Process Analysis].
    Okada K
    Yakugaku Zasshi; 2023; 143(11):897-903. PubMed ID: 37914336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
    Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
    Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nondestructive Investigation of the Agglomeration Process for Nanosuspensions via NMR Relaxation of Water Molecules.
    Okada K; Hayashi Y; Kumada S; Onuki Y
    Eur J Pharm Sci; 2021 Sep; 164():105908. PubMed ID: 34118410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
    Okumura T; Otsuka M
    Pharm Res; 2005 Aug; 22(8):1350-7. PubMed ID: 16078145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-state NMR analysis of crystalline and amorphous Indomethacin: An experimental protocol for full resonance assignments.
    Lu X; Xu W; Hanada M; Jermain SV; Williams RO; Su Y
    J Pharm Biomed Anal; 2019 Feb; 165():47-55. PubMed ID: 30503894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Applying Partial Least Squares Regression to T
    Chiba Y; Okada K; Hayashi Y; Kumada S; Onuki Y
    J Pharm Sci; 2023 Apr; 112(4):1041-1051. PubMed ID: 36462711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-domain NMR analysis for the determination of water content in pharmaceutical ingredients and wet granules.
    Ohgi K; Hayashi Y; Tsuji T; Ito T; Leong KH; Usuda S; Kumada S; Okada K; Onuki Y
    Int J Pharm; 2021 Jul; 604():120770. PubMed ID: 34111545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quantitative analysis of crystallinity using FT-Raman spectroscopy.
    Taylor LS; Zografi G
    Pharm Res; 1998 May; 15(5):755-61. PubMed ID: 9619786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Applications of Relaxation Filter-Selective Signal Excitation Methods for ¹⁹F Solid-State Nuclear Magnetic Resonance: Case Study With Atorvastatin in Dosage Formulation.
    Asada MN; Nemoto T; Mimura H
    J Pharm Sci; 2016 Mar; 105(3):1233-8. PubMed ID: 26886305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Hardness of a Pharmaceutical Oral Jelly by Using T
    Tsuji T; Kobayashi R; Hayashi Y; Kumada S; Mizuguchi M; Okada K; Onuki Y
    Chem Pharm Bull (Tokyo); 2022; 70(8):558-565. PubMed ID: 35908922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the degree of indomethacin crystallinity by chemoinfometrical Fourier-transformed [corrected] near-infrared spectroscopy and conventional powder X-ray diffractometry.
    Otsuka M; Kato F; Matsuda Y
    AAPS PharmSci; 2000; 2(1):E9. PubMed ID: 11741225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of indomethacin crystallinity in the presence of excipients using diffuse reflectance near-infrared spectroscopy.
    Seyer JJ; Luner PE
    Pharm Dev Technol; 2001 Nov; 6(4):573-82. PubMed ID: 11775958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manufacturing Amorphous Solid Dispersions with a Tailored Amount of Crystallized API for Biopharmaceutical Testing.
    Theil F; Milsmann J; Anantharaman S; van Lishaut H
    Mol Pharm; 2018 May; 15(5):1870-1877. PubMed ID: 29648833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.